Evidence for SMAD 3 as a modifier of breast cancer risk in BRCA 2 mutation carriers
暂无分享,去创建一个
V. Pankratz | F. Couch | T. Rebbeck | R. Eeles | A. Spurdle | D. Easton | M. Nelen | A. Antoniou | H. Olsson | B. Agnarsson | D. Eccles | D. Evans | G. Chenevix-Trench | H. Nevanlinna | P. Devilee | A. Ouweland | J. Beesley | Xiaoqing Chen | K. Nathanson | Q. Waisfisz | A. Meindl | R. Schmutzler | Xianshu Wang | T. Heikkinen | M. Hooning | C. Asperen | L. McGuffog | A. Godwin | B. Wappenschmidt | S. Domchek | D. Stoppa-Lyonnet | Z. Fredericksen | N. Lindor | R. Tarrell | S. Peock | M. Cook | C. Oliver | D. Frost | O. Sinilnikova | S. Mazoyer | F. Hogervorst | C. Engel | C. Singer | D. Gschwantler-Kaulich | C. Szabo | J. Fricker | L. Walker | F. Lalloo | M. Ausems | B. Arver | P. Karlsson | B. Melin | I. Schönbuchner | C. Aalfs | L. Izatt | R. Davidson | S. Healey | M. Caligo | J. Cook | C. Delnatte | H. Deissler | G. Pfeiler | P. Harrington | D. Muller | S. Giraud | K. Ong | C. Tirapo | A. Liljegren | C. Chu | M. Gerrits | A. Dressler | U. Kristoffersson | M. Verheus | ModSQuaD
[1] Christiana Kartsonaki,et al. A locus on 19p13 modifies risk of breast cancer in BRCA1 mutation carriers and is associated with hormone receptor–negative breast cancer in the general population , 2010, Nature Genetics.
[2] M. Beckmann,et al. Association between a germline OCA2 polymorphism at chromosome 15q13.1 and estrogen receptor-negative breast cancer survival. , 2010, Journal of the National Cancer Institute.
[3] A. Antoniou,et al. The Leu33Pro polymorphism in the ITGB3 gene does not modify BRCA1/2-associated breast or ovarian cancer risks: results from a multicenter study among 15,542 BRCA1 and BRCA2 mutation carriers , 2010, Breast Cancer Research and Treatment.
[4] G Rennert,et al. Evaluation of a candidate breast cancer associated SNP in ERCC4 as a risk modifier in BRCA1 and BRCA2 mutation carriers. Results from the Consortium of Investigators of Modifiers of BRCA1/BRCA2 (CIMBA) , 2009, British Journal of Cancer.
[5] Mads Thomassen,et al. Common variants in LSP1, 2q35 and 8q24 and breast cancer risk for BRCA1 and BRCA2 mutation carriers. , 2009, Human molecular genetics.
[6] J. Benítez,et al. The TP53 Arg72Pro and MDM2 309G>T polymorphisms are not associated with breast cancer risk in BRCA1 and BRCA2 mutation carriers , 2009, British Journal of Cancer.
[7] M. Barcellos-Hoff,et al. Transforming growth factor-β in breast cancer: too much, too late , 2009, Breast Cancer Research.
[8] K. Hess,et al. Decreased TGFβ signaling and increased COX2 expression in high risk women with increased mammographic breast density. , 2009 .
[9] K. Czene,et al. No evidence that GATA3 rs570613 SNP modifies breast cancer risk , 2009, Breast Cancer Research and Treatment.
[10] F. Couch,et al. No association of TGFB1 L10P genotypes and breast cancer risk in BRCA1 and BRCA2 mutation carriers: a multi-center cohort study , 2009, Breast Cancer Research and Treatment.
[11] F. Couch,et al. Common breast cancer predisposition alleles are associated with breast cancer risk in BRCA1 and BRCA2 mutation carriers , 2008 .
[12] M. Urioste,et al. The Average Cumulative Risks of Breast and Ovarian Cancer for Carriers of Mutations in BRCA1 and BRCA2 Attending Genetic Counseling Units in Spain , 2008, Clinical Cancer Research.
[13] C. Pipper,et al. [''R"--project for statistical computing]. , 2008, Ugeskrift for laeger.
[14] A. Spurdle,et al. Use of expression data and the CGEMS genome-wide breast cancer association study to identify genes that may modify risk in BRCA1/2 mutation carriers , 2008, Breast Cancer Research and Treatment.
[15] F. Couch,et al. RAD51 135G-->C modifies breast cancer risk among BRCA2 mutation carriers: results from a combined analysis of 19 studies. , 2007, American journal of human genetics.
[16] R. Vierkant,et al. AURKA F31I Polymorphism and Breast Cancer Risk in BRCA1 and BRCA2 Mutation Carriers: A Consortium of Investigators of Modifiers of BRCA1/2 Study , 2007, Cancer Epidemiology Biomarkers & Prevention.
[17] Lester L. Peters,et al. Genome-wide association study identifies novel breast cancer susceptibility loci , 2007, Nature.
[18] W. Willett,et al. A genome-wide association study identifies alleles in FGFR2 associated with risk of sporadic postmenopausal breast cancer , 2007, Nature Genetics.
[19] Georgia Chenevix-Trench,et al. An international initiative to identify genetic modifiers of cancer risk in BRCA1 and BRCA2 mutation carriers: the Consortium of Investigators of Modifiers of BRCA1 and BRCA2 (CIMBA) , 2007, Breast Cancer Research.
[20] M. King,et al. Familial clustering of site-specific cancer risks associated with BRCA1 and BRCA2 mutations in the Ashkenazi Jewish population. , 2006, Proceedings of the National Academy of Sciences of the United States of America.
[21] Leif E. Peterson,et al. Characterization of BRCA1 and BRCA2 mutations in a large United States sample. , 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[22] Bingshu E. Chen,et al. Prophylactic oophorectomy reduces breast cancer penetrance during prospective, long-term follow-up of BRCA1 mutation carriers. , 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[23] J. Chang-Claude,et al. A weighted cohort approach for analysing factors modifying disease risks in carriers of high‐risk susceptibility genes , 2005, Genetic epidemiology.
[24] K. Gunderson,et al. Illumina, Inc. , 2005, Pharmacogenomics.
[25] J. Hopper,et al. Average risks of breast and ovarian cancer associated with BRCA1 or BRCA2 mutations detected in case Series unselected for family history: a combined analysis of 22 studies. , 2003, American journal of human genetics.
[26] C. Heldin,et al. BRCA2 and Smad3 synergize in regulation of gene transcription , 2002, Oncogene.
[27] Susan L Neuhausen,et al. Prophylactic oophorectomy in carriers of BRCA1 or BRCA2 mutations. , 2002, The New England journal of medicine.
[28] D. Easton,et al. Estimates of the gene frequency of BRCA1 and its contribution to breast and ovarian cancer incidence. , 1995, American journal of human genetics.
[29] D. Easton,et al. Breast and ovarian cancer incidence in BRCA1-mutation carriers. Breast Cancer Linkage Consortium. , 1995, American journal of human genetics.